- Ticker
- ABOS
- Price
- 5.47
- Stock movement up
- +0.43 (8.53%)
- Company name
- Acumen Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 221.54M
- Ent value
- 116.78M
- Price/Sales
- -
- Price/Book
- 1.03
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -67.94%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2022-08-25
DIVIDENDS
ABOS does not pay dividends
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 1.03 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 40.50M |
| EPS (TTM) | -2.16 |
| FCF per share (TTM) | -0.63 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -25.00M |
| Net income (TTM) | -82.74M |
| EPS (TTM) | -2.16 |
| EPS (1y forward) | -1.18 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 108.76M |
| Net receivables | 158.00K |
| Total current assets | 192.10M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 220.09M |
| Accounts payable | 1.22M |
| Short/Current long term debt | 201.00K |
| Total current liabilities | 3.94M |
| Total liabilities | 4.00M |
| Shareholder's equity | 216.09M |
| Net tangible assets | 216.09M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -23.89M |
| Capital expenditures (TTM) | 55.00K |
| Free cash flow (TTM) | -23.95M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -38.29% |
| Return on Assets | -37.59% |
| Return on Invested Capital | -38.26% |
| Cash Return on Invested Capital | -11.07% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.13 |
| Daily high | 5.57 |
| Daily low | 5.12 |
| Daily Volume | 31K |
| All-time high | 20.28 |
| 1y analyst estimate | 16.67 |
| Beta | - |
| EPS (TTM) | -2.16 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ABOS | S&P500 | |
| Current price drop from All-time high | -73.03% | -13.41% |
| Highest price drop | -84.81% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -56.88% | -11.38% |
| Avg time to new high | 290 days | 12 days |
| Max time to new high | 289 days | 1805 days |
COMPANY DETAILS
Marketcap
221.54M
Marketcap category
Small-cap
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Employees
14
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found